BDTX vs DNLI Stock Comparison
Compare BDTX and DNLI across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between BDTX and DNLI?
DNLI leads the current stock comparison as Denali Therapeutics Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Black Diamond Therapeutics, Inc. vs Denali Therapeutics Inc.
DNLI leads
DNLI leads by 6 AIQ points, primarily on Risk Resilience, and the lead has widened from 2 points over 30 sessions. Wall Street currently favors BDTX on target upside.
Competitive: 3 of 5 evidence groups support DNLI, its lead is widening, and its current signal state is conflicted.
Black Diamond Therapeutics, Inc.
Denali Therapeutics Inc.
The Algovestiq AIQ Score currently favors DNLI over BDTX, 37 versus 31 as of Sep 11, 2026. DNLI's advantage is driven primarily by stronger risk resilience. DNLI also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors BDTX. 3 of 5 covered evidence groups favor DNLI today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. DNLI lead: Strengthening — the AIQ differential moved from 2 to 6 points over 30 sessions.
Compare Black Diamond Therapeutics, Inc. and Denali Therapeutics Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare BDTX and DNLI against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience37 vs 70DNLI +33
- Quality27 vs 30Even
- Momentum31 vs 31Even
3 of 5 evidence groups favor DNLI. DNLI’s edge is concentrated in risk resilience.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum -18
New signals
- Downtrend Structure Active — bearish, trend, long horizon
Largest factor move: Risk Resilience +1
No new signals fired.
DNLI's lead widened by 6 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — BDTX and DNLI both carry a full feed there.
The central trade-off
DNLI (Denali Therapeutics Inc.): the stronger current systematic profile, led by risk resilience.
BDTX (Black Diamond Therapeutics, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 52.6% against 33.9%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
DNLIDNLI on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
DNLIDNLI on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EvenThe two are level on Momentum.
Lower downside
DNLIDNLI on Risk Resilience, by 33 points.
Analyst upside
BDTXBDTX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors DNLI, analyst targets favor BDTX. That disagreement is the most useful thing on this page.
| Measure | BDTX | DNLI | Note |
|---|---|---|---|
| Implied upside to target | +304% | +55.4% | BDTX has more room |
| Target dispersion | 0% | +54.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 1 | 6 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor DNLI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | DNLI | 31 vs 37 |
| Fundamentals | Even | revenue growth 0% vs 0%; EPS growth -6.3% vs 1.4%; TTM ROE -38.8% vs -55.3% |
| Valuation | Not covered | Not covered |
| Technicals | DNLI | Price vs 50-day 0.7% vs -12.8%; vs 200-day -17.3% vs 2.4% |
| Risk Resilience | DNLI | Risk Resilience 37 vs 70 |
| Analyst expectations | BDTX | Target upside 304% vs 55.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BDTX and DNLI and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 6 points.
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DNLI.
How the comparison changed
119 daily snapshots · May 4 – Sep 10DNLI lead: Strengthening — the AIQ differential moved from 2 to 6 points over 30 sessions.
- Today
- DNLI +6
- 31 vs 37
- 7 sessions ago
- BDTX +3
- 41 vs 38
- 30 sessions ago
- DNLI +2
- 45 vs 47
- 90 sessions ago
- DNLI +9
- 40 vs 49
The lead changed hands 4 times in this window, most recently on Aug 24 when BDTX moved ahead of DNLI.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 3 bearish / 1 neutral
- Death Cross Active — bearish, trend, long horizon (20.52%)
- Downtrend Structure Active — bearish, trend, long horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.46%)
2 bullish / 2 bearish / 2 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (15.68%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
DNLI leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is up while the AIQ Score moved down 6 points over the same session — price and model disagree (price +1.02%, AIQ -6 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.45%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BDTX closes the Risk Resilience gap — currently 33 points behind, the largest single contributor to DNLI's edge.
- 2BDTX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3DNLI's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | BDTX | DNLI |
|---|---|---|
| Revenue growth (YoY) | 0% | 0% |
| EPS growth (YoY) | -6.3% | 1.4% |
| Gross margin | 0% | -61% |
| Operating margin | 0% | -150.6% |
| Return on equity (TTM) | -38.8% | -55.3% |
| Debt to equity | 0.18 | 0.03 |
Performance
DNLI leads 4 of 6 windows| Metric | BDTX | DNLI |
|---|---|---|
| 1 week (5 sessions) | -8.4% | -6.3% |
| 1 month (20 sessions) | -6.7% | -15.3% |
| 3 months (63 sessions) | 5.9% | 3.8% |
| 6 months (126 sessions) | -12.9% | -0.7% |
| Year to date | -19.3% | 29.6% |
| 1 year (252 sessions) | -35.7% | 39% |
Technicals
DNLI has the stronger structure| Metric | BDTX | DNLI |
|---|---|---|
| RSI (14) | 37.8 | 24.4 |
| ADX (14) | 25.3 | 25.8 |
| Price vs 50-day | 0.7% | -12.8% |
| Price vs 200-day | -17.3% | 2.4% |
| Volatility (1M, annualized) | 52.6% | 33.9% |
Risk
DNLI is the more resilient| Metric | BDTX | DNLI |
|---|---|---|
| Beta | 1.81 | 1.54 |
| Sharpe ratio | -0.22 | 0.8 |
| Sortino ratio | -0.28 | 1.2 |
| Max drawdown | -66.9% | -21.4% |
| Current drawdown | -59.8% | -21.4% |
| Annualized volatility | 82.6% | 56.8% |
| Value at risk (95%) | -7.2% | -5.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BDTX or DNLI?
On the Algovestiq AIQ Score, DNLI is the stronger of the two as of Sep 11, 2026, scoring 37 against BDTX's 31. The edge comes from risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BDTX or DNLI the better buy right now?
DNLI carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor DNLI over BDTX?
The composite weights Quality, Value, Momentum and Risk Resilience. DNLI leads Risk Resilience by 33 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BDTX or DNLI?
Analyst price targets imply +304% upside for BDTX and +55.4% for DNLI, so the Street currently favors BDTX. That points the opposite way to the AIQ Score, which favors DNLI. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BDTX or DNLI?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BDTX or DNLI?
DNLI on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BDTX or DNLI?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BDTX or DNLI?
DNLI is the more resilient of the two, so the other name carries the higher downside risk. DNLI on Risk Resilience, by 33 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BDTX more profitable than DNLI?
BDTX leads on the comparable margin measures — gross margin 0% vs -61%; operating margin 0% vs -150.6%; ttm roe -38.8% vs -55.3%.
Is DNLI's lead over BDTX getting stronger or weaker?
DNLI lead: Strengthening — the AIQ differential moved from 2 to 6 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-08-24, when BDTX moved ahead of DNLI.
What would change the BDTX vs DNLI verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BDTX closes the Risk Resilience gap — currently 33 points behind, the largest single contributor to DNLI's edge; BDTX's Death Cross Active resolves — a bearish trend rule currently active against it; DNLI's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about BDTX and DNLI?
BDTX: 0 bullish / 3 bearish / 1 neutral. DNLI: 2 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BDTX is Death Cross Active (bearish, long horizon). On DNLI it is Golden Cross Active (bullish, long horizon).
Compare BDTX and DNLI with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.